Allergan reiterated its opposition to Valeant's $53 billion hostile takeover offer, despite the recent calls from big shareholders to start negotiating.
from WSJ.com: US Business http://online.wsj.com/articles/allergan-reiterates-opposition-to-valeant-bid-1411994465?mod=pls_whats_news_us_business_f
via IFTTT
from WSJ.com: US Business http://online.wsj.com/articles/allergan-reiterates-opposition-to-valeant-bid-1411994465?mod=pls_whats_news_us_business_f
via IFTTT
No comments:
Post a Comment